Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple leg moves might boost circulation in Brain-Injured ICU patients

NCT ID NCT07524790

Knowledge-focused Sponsor: Abant Izzet Baysal University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether gentle, passive leg exercises (called PNF) can improve blood flow and vital signs in unconscious patients in a neurological intensive care unit. Researchers will measure ankle blood pressure, heart rate, and oxygen levels before and after the exercises. The goal is to see if these simple movements can help prevent circulation problems in patients who cannot move on their own.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients being monitored in the neurology intensive care unit * Aged 18 years or over * Haemodynamically stable * No orthopaedic condition preventing the performance of passive joint movements in the upper and lower limbs * A signed informed consent form from a patient's next of relative for participation in the study Exclusion Criteria: * Presence of haemodynamic instability * Fractures, contractures or serious orthopaedic conditions in the upper or lower limbs that restrict movement * Diagnosis or suspicion of deep vein thrombosis * Severe peripheral arterial disease * Serious cardiac arrhythmia that may prevent exercise

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neurologic disorder are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

nervous system disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neurologic disorder

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.